Condition: Migraine · Sponsor: Muhammad Aamir Latif
Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent. Therefore, the current study has been planned to evaluate and compare the effectiveness of flunarizine and propranolol in reducing migraine frequency in children aged 8-15 using the Pediatric Migraine Disability Assessment Scale (PedMIDAS) score.
This description comes directly from the study's public registry record.
Ishafaq Ahmed, FCPS · +923334957171 · quaidian245ishfaq@gmail.com
Muhammad Zia-ur-Rehman, FCPS · +923334202863 · drzia81@gmail.com
Always discuss trial participation with your own doctor first.
| The Children's Hospital Lahore | Lahore, Punjab Province, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07354126